|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 401/14 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3747880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18902212.2 |
| Date of filing the European patent application | 2018-12-27 | |
| (97) | Date of publication of the European application | 2020-12-09 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2018/124418 |
| Date | 2018-12-27 |
| (87) | Number | WO 2019/144759 |
| Date | 2019-08-01 |
| (30) | Number | Date | Country code |
| 201810084351 | 2018-01-29 | CN |
| (72) |
FENG, Yuzhen , CN
FANG, Lan , CN
|
| (73) |
Xuanzhu Biopharmaceutical Co., Ltd. ,
Beijing-Tianjin-Hebei Collaborative
Innovation Demonstration Park 203C507
No.769 Taihang Street
High-tech District, Shijiazhuang, Hebei Province,
CN
|
| (54) | CRYSTAL FORM TARGETING CDK4/6 KINASE INHIBITOR |
| CRYSTAL FORM TARGETING CDK4/6 KINASE INHIBITOR |